Mr. Patel joined Vaxart as Vice President of Regulatory Affairs in March 2018. Mr. Patel has been a partner and key member of senior management and scientific project teams in successful start-ups to clinical-stage organizations. Mr. Patel’s background includes global experience in regulatory affairs, quality assurance, analytical development, clinical operations and program management. Most recently, he served as Vice President of Regulatory Affairs at Aviragen Therapeutics, Inc. from 2014 to 2017. He was responsible for development and implementation of regulatory strategy for various clinical programs and management of QA tasks in clinical development of infectious disease therapies. Prior to joining Aviragen, he was Vice President of Regulatory/Quality at Inhibitex from 2010 to 2012, responsible for execution of regulatory and quality initiatives focused on infectious diseases. He also has experience in the therapeutic areas of metabolic diseases and autoimmune indications. Mr. Patel received a B.S. in biochemistry from Suffolk University and Master of Liberal Arts (ALM) in biology from Harvard University. He has received Regulatory Affairs Certification (RAC) for the U.S. and EU from the Regulatory Affairs Professionals Society.
